AC
MBIO icon

Armistice Capital’s Mustang Bio MBIO Stock Holding History

Armistice Capital’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-72,131
Closed -$638K – 267
2024
Q4 		$638K Buy
+72,131
New +$796K 0.01% 173
2024
Q2 		– Sell
-4,200
Closed -$218K – 336
2024
Q1 		$218K Sell
4,200
-4,515
-52% -$287K ﹤0.01% 265
2023
Q4 		$588K Buy
+8,715
New +$692K 0.01% 193

Other funds holding MBIO

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Armistice Capital's MBIO Position: Q1 2025 in Review

Armistice Capital sold out of Mustang Bio (MBIO) in Q1 2025, closing a stake of 72,131 shares — an estimated $638K sold.

Armistice Capital first reported a position in MBIO in Q4 2023 and held it in 3 quarters. The position peaked at $638K in Q4 2024. 16 funds tracked by Wall St. Rank hold MBIO as of Q1 2025.

  • Armistice Capital reported no remaining Mustang Bio position as of Q1 2025 after selling out during the quarter.
  • Armistice Capital sold 72,131 Mustang Bio shares in Q1 2025, an estimated $638K.
  • Armistice Capital first reported a position in Mustang Bio in Q4 2023 and held it in 3 quarters.
  • Armistice Capital's Mustang Bio position peaked at $638K in Q4 2024.
  • 16 funds tracked by Wall St. Rank held Mustang Bio as of Q1 2025.

Based on Armistice Capital's 13F filing for Q1 2025, filed 15 May 2025.